|
DAP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63077999999484E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57700000003036E-06 |
| Normal-vs-Stage2 |
6.817600E-02 |
| Normal-vs-Stage3 |
1.678910E-03 |
| Normal-vs-Stage4 |
2.750000E-01 |
| Stage1-vs-Stage2 |
2.801200E-01 |
| Stage1-vs-Stage3 |
8.787400E-01 |
| Stage1-vs-Stage4 |
5.665600E-02 |
| Stage2-vs-Stage3 |
3.474000E-01 |
| Stage2-vs-Stage4 |
5.331200E-01 |
| Stage3-vs-Stage4 |
1.135180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.35709999999445E-05 |
| Normal-vs-AfricanAmerican |
7.030300E-04 |
| Normal-vs-Asian |
9.607200E-01 |
| Caucasian-vs-AfricanAmerican |
4.281600E-01 |
| Caucasian-vs-Asian |
3.302400E-01 |
| AfricanAmerican-vs-Asian |
1.564170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.618410E-04 |
| Normal-vs-Female |
4.03319999999763E-05 |
| Male-vs-Female |
5.602000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.347400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.6042999999577E-06 |
| Normal-vs-Age(61-80Yrs) |
3.397000E-03 |
| Normal-vs-Age(81-100Yrs) |
6.526400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.635000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.775800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.904800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.600000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.694400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.014000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.84739999999195E-05 |
| Normal-vs-Grade 2 |
8.64540000033998E-07 |
| Normal-vs-Grade 3 |
1.582560E-03 |
| Normal-vs-Grade 4 |
2.455200E-01 |
| Grade 1-vs-Grade 2 |
2.746600E-01 |
| Grade 1-vs-Grade 3 |
5.133700E-02 |
| Grade 1-vs-Grade 4 |
1.633530E-02 |
| Grade 2-vs-Grade 3 |
3.403000E-01 |
| Grade 2-vs-Grade 4 |
9.247700E-02 |
| Grade 3-vs-Grade 4 |
3.217200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.27719999998277E-06 |
| Normal-vs-ccB subtype |
9.564100E-02 |
| ccA subtype-vs-ccB subtype |
5.992300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.960800E-04 |
| Normal-vs-N1 |
2.225800E-01 |
| N0-vs-N1 |
6.294100E-02 |
|
|
